✦ LIBER ✦

Pharmacogenomics and therapeutic prospects in dementia

✍ Scribed by Ramón Cacabelos

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 599 KB
Volume: 258
Category: Article
ISSN: 1433-8491
DOI: 10.1007/s00406-007-1006-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic options in dementia

✍ L. Parnetti 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 34 KB

SERCA2a in Heart Failure: Role and Thera

SERCA2a in Heart Failure: Role and Therapeutic Prospects

✍ Davide Gianni; Joachim Chan; Judith K. Gwathmey; Federica del Monte; Roger J. Ha 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 79 KB

Prospective therapeutic studies in nephr

Prospective therapeutic studies in nephrolithiasis

✍ D. K. Ackermann 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 423 KB

Xenograft rejection: molecular mechanism

Xenograft rejection: molecular mechanisms and therapeutic prospects

✍ A. Azimzadeh; C. Meyer; C. Ravanat; J.-P. Cazenave; P. Wolf 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 261 KB

Th22 in inflammatory and autoimmune dise

Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention

✍ Ning Zhang; Hai-Feng Pan; Dong-Qing Ye 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 170 KB

Aptamers as therapeutic and diagnostic r

Aptamers as therapeutic and diagnostic reagents: problems and prospects

✍ Scott E Osborne; Ichiro Matsumura; Andrew D Ellington 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 502 KB

Aptamers are nucleic acid molecules that bind specific ligands. Barriers to the application of aptamers as therapeutic and diagnostic reagents have been overcome in the past several years. In particular, aptamers that bind biomedically relevant targets have proven to be efficacious at modifying cell